Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Gross Profit: 2020-2024

Historic Gross Profit for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $5.6 million.

  • Molecular Partners Ag's Gross Profit fell 75.03% to $196.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 28.49%. This contributed to the annual value of $5.6 million for FY2024, which is 27.91% down from last year.
  • Molecular Partners Ag's Gross Profit amounted to $5.6 million in FY2024, which was down 27.91% from $7.8 million recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Gross Profit ranged from a high of $196.8 million in FY2022 and a low of $5.6 million during FY2024.
  • For the 3-year period, Molecular Partners Ag's Gross Profit averaged around $70.1 million, with its median value being $7.8 million (2023).
  • Per our database at Business Quant, Molecular Partners Ag's Gross Profit spiked by 1,751.78% in 2022 and then plummeted by 96.02% in 2023.
  • Yearly analysis of 5 years shows Molecular Partners Ag's Gross Profit stood at $10.3 million in 2020, then grew by 3.31% to $10.6 million in 2021, then soared by 1,751.78% to $196.8 million in 2022, then slumped by 96.02% to $7.8 million in 2023, then decreased by 27.91% to $5.6 million in 2024.